As a new discovery in this work, the olfactory signaling factor (GFY regulator) has not been evaluated for its role in breast cancer and may therefore be used as a prediction target for the diagnosis, treatment, or prognosis of breast cancer in the future. Here, GFY is linked to breast carcinoma.